Study of Low-Dose Capecitabine Monotherapy for Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 1421-9794|56|2|166-170

ISSN： 0009-3157

Source： Chemotherapy, Vol.56, Iss.2, 2010-04, pp. : 166-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acceptable but Limited Efficacy of Capecitabine-Based Doublets in the First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Pilot Study

By  

Chemotherapy, Vol. 59, Iss. 3, 2013-12 ,pp. : 207-213

Karger

Access to resources Recommend Favorite

Prospective Study of Vinorelbine and Capecitabine Combination Therapy in Chinese Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes

By  

Chemotherapy, Vol. 56, Iss. 4, 2010-08 ,pp. : 340-347

Karger

Access to resources Recommend Favorite

Gemcitabine and Capecitabine Combination Chemotherapy in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and/or Taxanes

By  

Chemotherapy, Vol. 61, Iss. 4, 2016-02 ,pp. : 171-178

Karger

Access to resources Recommend Favorite

Dose Escalation Study of Epirubicin and Docetaxel in Patients with Advanced or Recurrent Breast Cancer

By  

Chemotherapy, Vol. 54, Iss. 5, 2008-08 ,pp. : 379-385

Karger

Access to resources Recommend Favorite

Prospective Study of Empiric Monotherapy with Ceftazidime for Low-Risk Grade IV Febrile Neutropenia after Cytotoxic Chemotherapy in Cancer Patients

By  

Chemotherapy, Vol. 52, Iss. 4, 2006-06 ,pp. : 185-189

Karger

Access to resources Recommend Favorite